Sign In
Buy CHHHF
$2.31
+0 (+0%)
At Close: Jun 22, 2026
CareRx Corporation to Host Second Quarter 2025 Financial Results Conference Call on Thursday, July 31, 2025 at 8:30 a.m. ET
07:00am, Monday, 21'st Jul 2025
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call, including a slide presentation, to disc
CareRx Corporation to Host First Quarter 2025 Financial Results Conference Call on Wednesday, May 7, 2025 at 10:30 a.m. ET
07:00am, Wednesday, 30'th Apr 2025
Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or "the Company") today announced it will host a conference call, including a slide presentation, to disc
CareRx Corporation to Host Fourth Quarter 2024 Financial Results Conference Call on Wednesday, March 5, 2025 at 8:30 a.m. ET
04:34pm, Tuesday, 25'th Feb 2025
Toronto, Ontario--(Newsfile Corp. - February 25, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or "the Company") today announced it will host a conference call, including a slide presentation,
CareRx Corporation posts 4Q 2022 results reflecting a year of "exceptional progress"
08:06am, Thursday, 09'th Mar 2023
CareRx Corporation (TSX:CRRX) has reported its financial results for the fourth quarter ended December 31, 2022, during which a key success was winning a multi-year contract to provide pharmacy servic
CareRx earns repeat ‘Buy' rating from Canaccord analysts with reduced price target following equity financing
01:48pm, Thursday, 19'th Jan 2023
Canaccord Genuity (TSX:CF, LSE:CF) analysts have reiterated their ‘Buy' rating for CareRx Corporation (TSX:CRRX) but reduced their price target after the Canadian healthcare company raised equity f
CareRx closes $12.1 million financing to boost treasury
09:48am, Wednesday, 18'th Jan 2023
CareRx Corporation (TSX:CRRX) announced that it has completed its bought deal public offering and closed the first tranche of the concurrent private placement for aggregate gross proceeds of around $1
CareRx's 3Q results "solid" in spite of inflationary headwinds and healthcare spending, analysts say
04:12pm, Wednesday, 09'th Nov 2022
Long-term care pharmacy service provider CareRx Corporation (TSX:CRRX) has managed to withstand the macro challenges facing its business, according to analysts at Leede Jones Gable. The company posted
